Bioanalysis Special Focus Issue on Antibody–Drug Conjugates
Author:
- 3 May 2013
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 5 (9) , 981-983
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- PK Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab EmtansineBioanalysis, 2013
- Characterization of The Drug-To-Antibody Ratio Distribution for Antibody–Drug Conjugates in Plasma/SerumBioanalysis, 2013
- Immunogenicity Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab EmtansineBioanalysis, 2013
- Novel Detection of DNA-Alkylated Adducts of Antibody–Drug Conjugates with Potentially Unique Preclinical and Biomarker ApplicationsBioanalysis, 2013
- Bioanalysis of Antibody–Drug Conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group Position PaperBioanalysis, 2013
- Immunogenicity Testing Strategy and Bioanalytical Assays for Antibody–Drug ConjugatesBioanalysis, 2013
- Bioanalytical Assay Strategies for The Development of Antibody–Drug Conjugate BiotherapeuticsBioanalysis, 2013
- Trastuzumab Emtansine for HER2-Positive Advanced Breast CancerNew England Journal of Medicine, 2012
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesNature Biotechnology, 2012
- Antibody Conjugate Therapeutics: Challenges and PotentialClinical Cancer Research, 2011